Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
Haiyong Wang,1,2 Hui Zhu,2 Li Kong,2 Jinming Yu2 1Department of Oncology, School of Medicine, Shandong University, 2Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of Chi...
Main Authors: | Wang HY, Zhu H, Kong L, Yu JM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-cisplatinpemetrexed-with-bevacizumab-to-treat-advanced-lun-peer-reviewed-article-OTT |
Similar Items
-
Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
by: Xin Li, et al.
Published: (2021-05-01) -
Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell
by: Jonathan González García, et al.
Published: (2017-01-01) -
A Randomized, Controlled, Multicenter Clinical Trial Comparing Pemetrexed/Cisplatin and Gemcitabine/Cisplatin as First-line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer
by: Yan HUANG, et al.
Published: (2012-10-01) -
Efficacy and Toxicity of Maintenance Pemetrexed Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Non-small-cell Non-squamous Carcinoma of the Lung
by: Kim D. H., et al.
Published: (2015-06-01) -
Effects of endostatin combined with pemetrexed and cisplatin on the levels of TNF-α, NSE, CEA, CA199, AFP and CYFRA21-1 in patients with advanced lung adenocarcinoma
by: Min Zhang, et al.
Published: (2017-10-01)